Revaccination

After the vaccination, a specific anticancer immune response is triggered in our body which maintains for next 6 months in an adequate level. During the first and successive revaccinations even more vigorous anticancer immune responses are triggered due to the T-memory cells formed in the previous vaccination, which is held in an adequate level for even longer period (1.5 years as shown in Fig. 1). Revaccination is necessary to carry out in order to regain and maintain the anticancer immune activities in an optimum level.

The second vaccination is carried out with a single dose of 800 mg (4 vials) of RESAN. For the revaccinations a packet of 2-4 vials (400-800 mg) of anticancer vaccine RESAN is used. The content of each vial is dissolved in 1.5 millilitre 0.9 % solution of sodium chloride. The injections are carried out endermic, in one shot, under a special scheme.

The second vaccination is carried out after 6 months. The first revaccination is carried out after 1.5. The successive revaccinations are carried out in every 3-5 years.

In usual cases or in rational use of vaccine, after the revaccination the anticancer immunity maintains in an adequate level for next 3-5 years.

However, in case of the immunotherapy of advanced cancers or immunotherapy of cancers with out surgical resections, after the first revaccination the state of anticancer immunity may become inefficient to stand against the remaining or new cancer cells already after 1 year. In such cases, the second revaccination is recommended after 1 year (instead 3-5 years), and successive revaccinations in every next 1-1.5 years in order to keep the antitumor immune state in an adequate level.

Fig. 1